Reactive arthritis medical therapy

Jump to navigation Jump to search

Reactive arthritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Reactive arthritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Reactive arthritis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Reactive arthritis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Reactive arthritis medical therapy

CDC on Reactive arthritis medical therapy

Reactive arthritis medical therapy in the news

Blogs onReactive arthritis medical therapy

Directions to Hospitals Treating Reactive arthritis

Risk calculators and risk factors forReactive arthritis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

  • Reactive arthritis is generally seen with preceeding GI or GU infections. Antibiotics may be given if there is an ongoing infection, but generally patients of reactive arthritis are not advised antibiotic therapy. Recent studies have shown that antibiotic therapy does not alter the course of disease and their role is not completely established.[1]
  • Pharmacologic medical therapies for reactive arthritis include symptomatic control:
    • 1.1 NSAIDs such as the COX-2 inhibitors
      • Preferred regimen (1): Naproxen 500 mg PO q8-12h daily.
      • Preferred regimen (2): Diclofenac 50 mg PO q8h daily.
      • Preferred regimen (3): Indomethacin 50 mg PO q6-8h daily.
      Note(1):NSAIDs are usually given for a duration of two weeks
      Note(1):NSAIDs are contraindicated in patients with GI bleeding, heart disease and renal disease.

and If patients does not have

Antimicrobial regimen

References

  1. Barber CE, Kim J, Inman RD, Esdaile JM, James MT (June 2013). "Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis". J. Rheumatol. 40 (6): 916–28. doi:10.3899/jrheum.121192. PMID 23588936.


Template:WikiDoc Sources